Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients

BACKGROUND: Beta-amyloid (Abeta) and tau protein in cerebrospinal fluid (CSF) are established diagnostic biomarkers for Alzheimer’s disease (AD). However, these biomarkers may not the only ones existing parameters that reflect Alzheimer’s disease neuropathological change. The use of quantitative met...

Descripción completa

Detalles Bibliográficos
Autores principales: Berezhnoy, Georgy, Laske, Christoph, Trautwein, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483152/
https://www.ncbi.nlm.nih.gov/pubmed/37693649
http://dx.doi.org/10.3389/fnagi.2023.1219718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483152/
https://www.ncbi.nlm.nih.gov/pubmed/37693649
http://dx.doi.org/10.3389/fnagi.2023.1219718

Ejemplares similares